Default company panoramic image

Anima Cell Metrology, Inc

Anima is developing "live proteomics", measuring and analyzing the process of protein synthesis in real time, from living cells.

  • Stage Concept Only
  • Industry Not Set
  • Location Ilan's, Ibn Gabirol, Tel Aviv, Tel Aviv District, Israel
  • Currency USD
  • Website

Company Summary

Anima's pioneering approach calls for monitoring the process of protein synthesis, in living cell, in real time, by labeling the translation apparatus with fluorescent probes. This approach is unique, and the data that it produces is currently unavailable. Anima will sell protein monitoring kits and specialized assays to research labs, pharmaceutical and biotechnology companies, and government organizations.


  • Default avatar
    Roni Appel
    CEO & President

    Mr. Appel has served as CEO of Anima since 2008. Before joining Anima Mr. Appel has served as CEO of Advaxis Inc (OTCBB: ADXS.OB) a pioneer of cancer vaccines. Before that, he has been a partner and managing director of LV Equity Partners. From 1998 until 1999, he was a director of business development at Americana Financial Services, Inc. From 1994 to 1998 he was an attorney and completed his M.B.A at Columbia University.

  • Default avatar
    Dr. Zeev Smilansky
    Founder & CSO

    Dr. Smilansky, inventor of PSM technology, is a mathematician with over 20 years experience in design and implementation of complex systems. He has served in key positions Procognia, Compugen, Applied Materials, Orbotech and Scitex. He is a recognized expert in image processing, holds a Ph.D. in Mathematics from the Hebrew University, Jerusalem and University College, London, and is the author of numerous scientific papers and patents.

  • Default avatar
    Richard C. Lufkin

    Mr. Lufkin held founder, general management, and corporate roles with DUSA Pharmaceuticals, Linguagen, Medical Market Specialties, Proanagen, ClinDAR, and Synectiq. Early in his career he held positions with Corning Inc., in venture capital, and Johnson & Johnson. Mr. Lufkin is an Electrical Engineering graduate of the Massachusetts Institute of Technology and holds an M.B.A. degree from the Wharton School of of the University of Pennsylvania.